scispace - formally typeset
A

Adrian Bomford

Researcher at University of Cambridge

Publications -  94
Citations -  6072

Adrian Bomford is an academic researcher from University of Cambridge. The author has contributed to research in topics: Hemochromatosis & Transferrin. The author has an hindex of 35, co-authored 90 publications receiving 5817 citations. Previous affiliations of Adrian Bomford include National Health Service & King's College London.

Papers
More filters
Journal ArticleDOI

A Novel Duodenal Iron-Regulated Transporter, IREG1, Implicated in the Basolateral Transfer of Iron to the Circulation

TL;DR: The isolation and characterization of a novel cDNA (Ireg1) encoding a duodenal protein that is localized to the basolateral membrane of polarized epithelial cells are described and it is concluded that IREG1 represents the long-sought duodental iron export protein and is upregulated in the iron overload disease, hereditary hemochromatosis.
Journal ArticleDOI

An iron-regulated ferric reductase associated with the absorption of dietary iron

TL;DR: A complementary DNA, Dcytb (for duodenal cytochrome b), was isolated, which encoded a putative plasma membrane di-heme protein in mouse duodensal mucosa, and provides an important element in the iron absorption pathway.
Journal ArticleDOI

Long Term Results of Venesection Therapy in Idiopathic Haemochromatosis

TL;DR: Ten patients with idiopathic haemochromatosis, all of whom had cirrhosis at the time of diagnosis, died of malignant hepatoma between three and 15 years after completing venesection therapy, strikingly higher than that rate predicted for a similarly aged population using national cancer mortality rates.
Journal ArticleDOI

Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis

TL;DR: The phenotype of C282Y heterozygotes and homozygotes may be modified by heterozygosity for mutations which disrupt the function of hepcidin in iron homeostasis, with the severity of iron overload corresponding to the severityof the HAMP mutation.

A simple genetic test identifies 90% of UK patients with haemochromatosis

TL;DR: In this article, the prevalence of the HLA-H associated C282Y and H63D mutations was determined by polymerase chain reaction amplification and restriction enzyme digestion in a cohort of 115 well characterised patients with GH and 101 controls from the United Kingdom.